SG Americas Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-19,600
| Closed | -$766K | – | 3613 |
|
|
2025
Q4 | $766K | Buy |
+19,600
| New | +$13.3M | ﹤0.01% | 2222 |
|
|
2025
Q2 | – | Sell |
-10,900
| Closed | -$127K | – | 3477 |
|
|
2025
Q1 | $127K | Buy |
10,900
+200
| +2% | +$138K | ﹤0.01% | 2875 |
|
|
2024
Q4 | $86K | Hold |
10,700
| – | – | ﹤0.01% | 2784 |
|
|
2024
Q3 | $1.07M | Hold |
10,700
| – | – | ﹤0.01% | 1034 |
|
|
2024
Q2 | $1.27M | Sell |
10,700
-16,400
| -61% | -$15.9M | 0.01% | 1190 |
|
|
2024
Q1 | $2.08M | Buy |
27,100
+11,600
| +75% | +$11M | 0.01% | 853 |
|
|
2023
Q4 | $1.16M | Sell |
15,500
-1,200
| -7% | -$988K | 0.01% | 946 |
|
|
2023
Q3 | $1.14M | Buy |
16,700
+5,400
| +48% | +$4.24M | 0.01% | 1160 |
|
|
2023
Q2 | $447K | Sell |
11,300
-7,400
| -40% | -$5.71M | ﹤0.01% | 1447 |
|
|
2023
Q1 | $1.36M | Buy |
18,700
+1,200
| +7% | +$905K | 0.02% | 927 |
|
|
2022
Q4 | $147K | Buy |
+17,500
| New | +$12.9M | ﹤0.01% | 2445 |
|
|
2022
Q2 | – | Sell |
-25,000
| Closed | -$908K | – | 3573 |
|
|
2022
Q1 | $908K | Buy |
25,000
+10,400
| +71% | +$6.58M | 0.01% | 1494 |
|
|
2021
Q4 | $518K | Buy |
14,600
+7,500
| +106% | +$4.61M | ﹤0.01% | 2158 |
|
|
2021
Q3 | $443K | Sell |
7,100
-30,000
| -81% | -$18.6M | ﹤0.01% | 2619 |
|
|
2021
Q2 | $1.24M | Buy |
37,100
+30,000
| +423% | +$15.2M | 0.01% | 1418 |
|
|
2021
Q1 | $181K | Sell |
7,100
-14,900
| -68% | -$7.25M | ﹤0.01% | 2738 |
|
|
2020
Q4 | $2.8M | Hold |
22,000
| – | – | 0.01% | 861 |
|
|
2020
Q3 | $4.32M | Hold |
22,000
| – | – | 0.03% | 399 |
|
|
2020
Q2 | $5.78M | Hold |
22,000
| – | – | 0.05% | 304 |
|
|
2020
Q1 | $3.22M | Sell |
22,000
-19,200
| -47% | -$7.92M | 0.03% | 567 |
|
|
2019
Q4 | $1.43M | Hold |
41,200
| – | – | 0.01% | 1045 |
|
|
2019
Q3 | $443K | Hold |
41,200
| – | – | ﹤0.01% | 1958 |
|
|
2019
Q2 | $905K | Buy |
41,200
+22,000
| +115% | +$7.32M | 0.01% | 1493 |
|
|
2019
Q1 | $282K | Sell |
19,200
-34,500
| -64% | -$14.2M | ﹤0.01% | 2318 |
|
|
2018
Q4 | $85K | Hold |
53,700
| – | – | ﹤0.01% | 2754 |
|
|
2018
Q3 | $841K | Buy |
53,700
+10,000
| +23% | +$3.81M | 0.01% | 1814 |
|
|
2018
Q2 | $261K | Hold |
43,700
| – | – | ﹤0.01% | 2431 |
|
|
2018
Q1 | $504K | Buy |
43,700
+30,000
| +219% | +$10.4M | ﹤0.01% | 1863 |
|
|
2017
Q4 | $157K | Hold |
13,700
| – | – | ﹤0.01% | 2607 |
|
|
2017
Q3 | $510K | Buy |
+13,700
| New | +$6.52M | ﹤0.01% | 1828 |
|
|
2016
Q1 | – | Sell |
-11,400
| Closed | -$61K | – | 3201 |
|
|
2015
Q4 | $61K | Buy |
+11,400
| New | +$6.18M | ﹤0.01% | 2448 |
|
|
2015
Q3 | – | Sell |
-10,100
| Closed | -$181K | – | 2593 |
|
|
2015
Q2 | $181K | Buy |
+10,100
| New | +$4.93M | ﹤0.01% | 2026 |
|
Other funds holding REGN
VCM
N
SG Americas Securities's REGN Position: Q1 2026 in Review
SG Americas Securities increased its Regeneron Pharmaceuticals (REGN) stake by 21% in Q1 2026, buying an estimated $20.8M and bringing the position to 158,278 shares worth $122M. The position accounts for 0.13% of the portfolio, ranked #131.
SG Americas Securities first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- SG Americas Securities held 158,278 shares of Regeneron Pharmaceuticals worth $122M as of Q1 2026.
- SG Americas Securities bought 27,166 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $20.8M.
- Regeneron Pharmaceuticals made up 0.13% of SG Americas Securities's portfolio in Q1 2026, its #131 holding.
- SG Americas Securities first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.